U.S., May 6 -- ClinicalTrials.gov registry received information related to the study (NCT07567443) titled 'A1-Free vs. Conventional Milk Metabolic Response Study' on April 28. Brief Summary: This stu... Read More
U.S., May 6 -- ClinicalTrials.gov registry received information related to the study (NCT07567287) titled 'A Basic Study Using Human Abdominal Adipose Tissue Biopsies to Characterize the Role of Endoc... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembro... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nera... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Do... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More
Singapore, May 6 -- The Health Sciences Authority received information related to the study titled 'Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)'. The following are the other ... Read More